Aims: Glutathione (GSH) is the main antioxidant against cell damage. Several pathological states course with reduced nucleophilic tone and perturbation of redox homeostasis due to changes in the 2GSH/GSSG ratio. Here, we investigated the regulation of the rate-limiting GSH biosynthetic heterodimeric enzyme γ-glutamyl-cysteine ligase (GCL) by microRNAs (miRNAs). Results: “In silico” analysis of the 3′- untranslated regions (UTRs) of both catalytic (GCLc) and regulatory (GCLm) subunits of GCL enabled an identification of miR-433 as a strong candidate for the targeting of GCL. Transitory overexpression of miR-433 in human umbilical vein endothelial cells (HUVEC) showed a downregulation of both GCLc and GCLm in a nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-independent manner. Increases in pro-oxidant stimuli such as exposure to hydrogen peroxide or GSH depletion in endothelial and hepatic cells caused an expected increase in GCLc and GCLm protein expression and abrogation of miR-433 levels, thus supporting a cross-regulation of these pathways. Treatment of HUVEC with miR-433 resulted in reduced antioxidant and redox potentials, increased S-glutathionylation, and reduced endothelial nitric oxide synthase activation. In vivo models of renal and hepatic fibrosis were associated with transforming growth factor β1 (TGF-β1)-related reduction of GCLc and GCLm levels that were miR-433 dependent. Innovation and Conclusion: We describe for the first time an miRNA, miR-433, capable of directly targeting GCL and promoting functional consequences in endothelial physiology and fibrotic processes by decreasing GSH levels. Antioxid. Redox Signal. 23, 1092–1105.
Get full access to this article
View all access options for this article.
References
1.
AmbrosV. microRNAs: tiny regulators with great potential. Cell, 107: 823–826, 2001.
2.
BakerAH and van RooijE. miRNA overexpression induces cardiomyocyte proliferation in vivo. Mol Ther, 21: 497–498, 2013.
3.
BakinAV, StourmanNV, SekharKR, RinehartC, YanX, MeredithMJ, ArteagaCL, and FreemanML. Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med, 38: 375–387, 2005.
Breton-RomeroR and LamasS. Hydrogen peroxide signaling in vascular endothelial cells. Redox Biol, 2: 529–534, 2014.
7.
BryanHK, OlayanjuA, GoldringCE, and ParkBK. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol, 85: 705–717, 2013.
8.
CrabtreeMJ, BrixeyR, BatchelorH, HaleAB, and ChannonKM. Integrated redox sensor and effector functions for tetrahydrobiopterin- and glutathionylation-dependent endothelial nitric-oxide synthase uncoupling. J Biol Chem, 288: 561–569, 2013.
9.
ChappleSJ, SiowRC, and MannGE. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol, 44: 1315–1320, 2012.
10.
ChenCA, WangTY, VaradharajS, ReyesLA, HemannC, TalukderMA, ChenYR, DruhanLJ, and ZweierJL. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature, 468: 1115–1118, 2010.
11.
ChengX, KuCH, and SiowRC. Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis. Free Radic Biol Med, 64: 4–11, 2013.
12.
DevarajanP. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl, 241: 89–94, 2008.
13.
EstebanV, LorenzoO, RuperezM, SuzukiY, MezzanoS, BlancoJ, KretzlerM, SugayaT, EgidoJ, and Ruiz-OrtegaM. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol, 15: 1514–1529, 2004.
14.
FormanHJ, DaviesKJ, and UrsiniF. How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic Biol Med, 66: 24–35, 2014.
15.
FranklinCC, BackosDS, MoharI, WhiteCC, FormanHJ, and KavanaghTJ. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med, 30: 86–98, 2009.
16.
FranklinCC, Rosenfeld-FranklinME, WhiteC, KavanaghTJ, and FaustoN. TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J, 17: 1535–1537, 2003.
17.
FuY, ZhengS, LuSC, and ChenA. Epigallocatechin-3-gallate inhibits growth of activated hepatic stellate cells by enhancing the capacity of glutathione synthesis. Mol Pharmacol, 73: 1465–1473, 2008.
18.
GuoH, IngoliaNT, WeissmanJS, and BartelDP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature, 466: 835–840, 2010.
19.
GutscherM, PauleauAL, MartyL, BrachT, WabnitzGH, SamstagY, MeyerAJ, and DickTP. Real-time imaging of the intracellular glutathione redox potential. Nat Methods, 5: 553–559, 2008.
20.
HayesJD and Dinkova-KostovaAT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci, 39: 199–218, 2014.
21.
HeckerL, LogsdonNJ, KurundkarD, KurundkarA, BernardK, HockT, MeldrumE, SandersYY, and ThannickalVJ. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med, 6: 231ra47, 2014.
22.
HuangCS, ChangLS, AndersonME, and MeisterA. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem, 268: 19675–19680, 1993.
23.
HuangKP and HuangFL. Glutathionylation of proteins by glutathione disulfide S-oxide. Biochem Pharmacol, 64: 1049–1056, 2002.
24.
HuangY, ShenXJ, ZouQ, WangSP, TangSM, and ZhangGZ. Biological functions of microRNAs: a review. J Physiol Biochem, 67: 129–139, 2011.
HuntzingerE and IzaurraldeE. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet, 12: 99–110, 2011.
27.
JardineH, MacNeeW, DonaldsonK, and RahmanI. Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1. J Biol Chem, 277: 21158–21166, 2002.
28.
KrejsaCM, FranklinCC, WhiteCC, LedbetterJA, SchievenGL, and KavanaghTJ. Rapid activation of glutamate cysteine ligase following oxidative stress. J Biol Chem, 285: 16116–16124, 2010.
29.
LangstonW, CircuML, and AwTY. Insulin stimulation of gamma-glutamylcysteine ligase catalytic subunit expression increases endothelial GSH during oxidative stress: influence of low glucose. Free Radic Biol Med, 45: 1591–1599, 2008.
30.
LaursenJB, BoesgaardS, TrautnerS, RubinI, PoulsenHE, and AldershvileJ. Endothelium-dependent vasorelaxation in inhibited by in vivo depletion of vascular thiol levels: role of endothelial nitric oxide synthase. Free Radic Res, 35: 387–394, 2001.
31.
LeonardoTR, SchultheiszHL, LoringJF, and LaurentLC. The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol, 14: 1114–1121, 2012.
32.
LiR, ChungAC, DongY, YangW, ZhongX, and LanHY. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta/Smad3-Azin1 pathway. Kidney Int, 84: 1129–1144, 2013.
33.
LiuRM, LiuY, FormanHJ, OlmanM, and TarpeyMM. Glutathione regulates transforming growth factor-beta-stimulated collagen production in fibroblasts. Am J Physiol Lung Cell Mol Physiol, 286: L121–L128, 2004.
34.
LiuRM, VayalilPK, BallingerC, DickinsonDA, HuangWT, WangS, KavanaghTJ, MatthewsQL, and PostlethwaitEM. Transforming growth factor beta suppresses glutamate-cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model. Free Radic Biol Med, 53: 554–563, 2012.
35.
LivakKJ and SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25: 402–408, 2001.
MoriMA, RaghavanP, ThomouT, BoucherJ, Robida-StubbsS, MacotelaY, RussellSJ, KirklandJL, BlackwellTK, and KahnCR. Role of microRNA processing in adipose tissue in stress defense and longevity. Cell Metab, 16: 336–347, 2012.
44.
NarasimhanM, PatelD, VedpathakD, RathinamM, HendersonG, and MahimainathanL. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One, 7: e51111, 2012.
OuyangY-B, CreedM, StaryCM, WhiteRE, and GiffardRG. The use of microRNAs to modulate redox and immune response to stroke. Antioxid Redox Signal, 22: 187–202, 2015.
47.
ParikhCR and DevarajanP. New biomarkers of acute kidney injury. Crit Care Med, 36: S159–S165, 2008.
48.
PastoreA and PiemonteF. S-Glutathionylation signaling in cell biology: progress and prospects. Eur J Pharm Sci, 46: 279–292, 2012.
49.
PatelV and NoureddineL. MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens, 21: 410–416, 2012.
50.
PeshavariyaHM, ChanEC, LiuGS, JiangF, and DustingGJ. Transforming growth factor-beta1 requires NADPH oxidase 4 for angiogenesis in vitro and in vivo. J Cell Mol Med, 18: 1172–1183, 2014.
51.
PottierN, CauffiezC, PerraisM, BarbryP, and MariB. FibromiRs: translating molecular discoveries into new anti-fibrotic drugs. Trends Pharmacol Sci, 35: 119–126, 2014.
52.
PoulsenHE, SpechtE, BroedbaekK, HenriksenT, EllervikC, Mandrup-PoulsenT, TonnesenM, NielsenPE, AndersenHU, and WeimannA. RNA modifications by oxidation: a novel disease mechanism?. Free Radic Biol Med, 52: 1353–1361, 2012.
53.
RamaniK, TomasiML, YangH, KoK, and LuSC. Mechanism and significance of changes in glutamate-cysteine ligase expression during hepatic fibrogenesis. J Biol Chem, 287: 36341–36355, 2012.
54.
RavuriC, SvinengG, and HusebyNE. Differential regulation of gamma-glutamyltransferase and glutamate cysteine ligase expression after mitochondrial uncoupling: gamma-glutamyltransferase is regulated in an Nrf2- and NFkappaB-independent manner. Free Radic Res, 47: 394–403, 2013.
55.
RyooIG, ShinDH, KangKS, and KwakMK. Involvement of Nrf2-GSH signaling in TGFbeta1-stimulated epithelial-to-mesenchymal transition changes in rat renal tubular cells. Arch Pharm Res, 2014 [Epub ahead of print]; DOI: DOI:10.1007/s122272-014-0380-y.
56.
Sanchez-GomezFJ, Espinosa-DiezC, DubeyM, DikshitM, and LamasS. S-glutathionylation: relevance in diabetes and potential role as a biomarker. Biol Chem, 394: 1263–1280, 2013.
57.
SangokoyaC, TelenMJ, and ChiJT. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood, 116: 4338–4348, 2010.
58.
SantoroMM and NicoliS. miRNAs in endothelial cell signaling: the endomiRNAs. Exp Cell Res, 319: 1324–1330, 2013.
59.
SeeligGF and MeisterA. Gamma-glutamylcysteine synthetase. Interactions of an essential sulfhydryl group. J Biol Chem, 259: 3534–3538, 1984.
60.
SenaCM, PereiraAM, and SeicaR. Endothelial dysfunction—a major mediator of diabetic vascular disease. Biochim Biophys Acta, 1832: 2216–2231, 2013.
61.
StaszelT, ZapalaB, PolusA, Sadakierska-ChudyA, Kiec-WilkB, StepienE, WybranskaI, ChojnackaM, and Dembinska-KiecA. Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn, 121: 361–366, 2011.
62.
SunWM, HuangZZ, and LuSC. Regulation of gamma-glutamylcysteine synthetase by protein phosphorylation. Biochem J, 320 (Pt 1): 321–328, 1996.
63.
TanKP, YangM, and ItoS. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress. Mol Pharmacol, 72: 1380–1390, 2007.
64.
Truong DoM, Gyun KimH, Ho ChoiJ, and Gwang JeongH. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1alpha/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Free Radic Biol Med, 74: 21–34, 2014.
UceroAC, GoncalvesS, Benito-MartinA, SantamariaB, RamosAM, BerzalS, Ruiz-OrtegaM, EgidoJ, and OrtizA. Obstructive renal injury: from fluid mechanics to molecular cell biology. Open Access J Urol, 2: 41–55, 2010.
67.
UngvariZ, TucsekZ, SosnowskaD, TothP, GautamT, PodlutskyA, CsiszarA, LosonczyG, Valcarcel-AresMN, and SonntagWE. Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells. J Gerontol A Biol Sci Med Sci, 68: 877–891, 2013.
68.
van RooijE, MarshallWS, and OlsonEN. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res, 103: 919–928, 2008.
69.
WeldyCS, LuttrellIP, WhiteCC, Morgan-StevensonV, BammlerTK, BeyerRP, AfsharinejadZ, KimF, ChitaleyK, and KavanaghTJ. Glutathione (GSH) and the GSH synthesis gene Gclm modulate vascular reactivity in mice. Free Radic Biol Med, 53: 1264–1278, 2012.
70.
WhiteK, DempsieY, CarusoP, WallaceE, McDonaldRA, StevensH, HatleyME, Van RooijE, MorrellNW, MacleanMR, and BakerAH. Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis. Hypertension, 64: 185–194, 2014.
71.
WildAC, MoinovaHR, and MulcahyRT. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem, 274: 33627–33636, 1999.
72.
YangH, KoK, XiaM, LiTW, OhP, LiJ, and LuSC. Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice. Hepatology, 51: 1291–1301, 2010.
73.
YangH, RamaniK, XiaM, KoKS, LiTW, OhP, LiJ, and LuSC. Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications. Hepatology, 49: 1982–1991, 2009.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
